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ABSTRACT 
To determine whether specific chemical linkage s between 
proteins and haptens could be important in cell-mediated immune 
recognition of drugs I Penicillin-G (PG) was covalently conjugated 
to guinea pig albumin through amino (NHZ) or sulfhydryl (SH) moietie s. 
Hapten densities ranged from four to one-hundred moles of PG per mole 
of albumin. Slight differences in cell-mediated immunity to the 
conjugates were observed for different hapten densities or doses 
of conjugate used for sensitization. Guinea pigs sensitized with 
PG-albumin conjugates through amino groups (PG-NHZ) responded 
to the PG- NH Z conjugate in vivo (delayed skin te st) and in vitro 
(Macrophage Migration Inhibition, MIF) but not to the PG-SH 
conjugate of albumin. Animals sensitized to PG-SH re sponded to 
the PG-SH conjugate I and not to the PG-NHZ conjugate. Penicilloyl-
polysysine (PPL) and PG were also tested for in vivo and in vitro 
efficacy to detect the hypersensitivity; PG alone did not result in 
any increase over baseline values and the inhibition of cellular 
migration from PG- NH 2 sensitized animals challenged with PPL was 
not statistically significant. In vitro dose response effect for the 
PG-NHZ conjugate suggest that the MIF assay is not as dose sensitive 
as lymphocyte transformation I where increased 3H -Thymidine uptake 




The detection of drug allergies is an important but difficult 
problem ( 1). Various types of skin tests are frequently used for the 
in vivo confirmation of allergy I but these tests only work for a few 
drugs I and can result in serious reactions( 2 ). Several serological 
methods are of value in the in vitro detection of antibody mediated 
drug allergies I but like skin tests I the correlation to in vivo events 
seems poor( 2 ). Other in vitro methods that require more time and 
specialized equipment to perform I measure the responses of various 
cells to antigen; e. g • I basophil degranulation I lymphocyte transfor-
mation and the production and detection of various lymphokine 
activities ( 3 ). 
Although immediate-type reactions may be triggered by 
haptens in previously sensitized individuals I the induction of both 
immediate and cell-mediated hypersensitivities to drugs apparently 
requires the conjugation of the drug, or a metabolite or breakdown 
product of the drug I to a macromolecular carrier ( 4 ) . Both hapten ( 5 ) 
and carrier (6 I 7 )specificities seem to be important in the in vivo 
andl!:! vitro elicitation of cell-mediated responses. Although not 
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absolute (8 ) I these specificity requirements cause problems for the 
in vitro detection of drug allergies I since an unknown drug metabolite I 
or a certain carrier specificity may be required in vitro to duplicate 
the in vivo conditions resulting in the allergic response. 
The penicillin group of antibiotics is the most common cause 
of allergic reactions to drugs (9 ). Penicillin is very reactive with 
proteins I and can form numerous I presumably different I antigens 
on combining with proteins (9). We present data which shows that 
penicillin I conjugated to a self-protein carrier (albumin) through 
different chemical likages I results in immune recognition specific 
for the antigen used to induce the hypersensitivity. Further I this 
recognition can be demonstrated by the .ill.. vitro technique s of 
Macrophage Migration Inhibition (MIF) and less convincingly by 
Lymphocyte Transformation (3H-Thymidine Incorporation). 
MATERIALS AND METHODS 
Mixed Conjugation of Penicillin G to Guinea Pig Albumin. 
Guinea pig albumin I 10 mg / ml (Sigma I Frac. V) in phosphate 
buffered saline (PBS) I 0.025 M in PO 4' pH= 7.4, was divided 
into two fractions, one for control, the other reacted with 200 mg/ml 
of Penicillin-G (PG) and 1 mc Ci of 14C-Iabeled PG (25 mCi/mM I 
Amersham Searle). Both fractions were sterile filtered (0.22 /J cm 
Millipore) into sterile plastic tubes (Falcon Plastics I 16 x 150 mm) 
. 
and incubated at 37oC. Mter 18, 40 and 72 hours, one third of the 
volume for each fraction was removed and dialyzed in the cold (4oC) 
against distilled water (4 x 1 liter) and PBS (4 x 1Uter) over 72 hours. 
Alliquots from each of the 3 conjugates were radioassayed by liquid 
scintillation to determine the quantity of PG_C 14 bound. Protein 
concentrations were determined by the method of Lowry. The 
average number of PG molecules bound per mole of albumin was 
calculated; the 40 and 72 hour conjugates bound approximately 40 
(38 -47) and 100 (95 - 113) moles of PG per mole of protein 
(PG40-GPA and PG100-GPA). Samples were diluted with PBS, and 
frozen (-20oC). 
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Conjugation of Penicillin to Free Amino (NH2 ) Groups on 
Albumin. To remove PG bound through disulfide or thiolester bonds 
to sulfhydryl groups on albumin while leaving penicilloyl (PG-NH2) 
bonds intact, the 18 hour control and conjugate fractions from above 
were adjusted to pH = 8.0 with NaOH and beta-mercaptoethanol 
(/3 - M. E.) added to a final concentration of 1.0 Molar( 10 ) . This 
treatment precipitated the albumin which was re solubilized by 
adding NaOH to pH = II, and the fractions were then dialyzed in 
the cold against PBS (6 x 1 liter , 48 hours to adjust the pH and to 
remove the /3 - M. E. and unbound PG. This conjugate is referred 
to as PG-NH2 or PG I5 -GPA, since an average of 15 moles of PG 
were bound per mole of albumin. 
Conjugation of Penicillin to Albumin Through a Disulfide 
(-S-S-) Linkage. To convert the protein SH groups to disulfides, 
0.25 ml of Ellman's Reagent (5, 5' Dithiobis, 2-nitrobenzoic acid, 
DTNB ) was added to 25 ml of guinea pig albumin (I 0 mg / ml in O. 1 
M phosphate buffer, pH = 8.0). Mter 30 min incubation (room 
temp.) the solution was sterile filtered I and dialyzed in the cold 
against distilled water 3X and PBS 3X (48 hours). The sample was 
divided into two fractions, to one PG (200 mg / ml) and 14C _PG 
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tracer (1 mcCi) were added I the other fraction was kept for control. 
Penicillin reacts with the thionltrobenzoate-protein through disulfide 
interchange (10) to form a PG-albumin disulfide bonded conjugate 
(PG-SH). Reaction time for the disulfide interchange was kept short 
(25 min) to prevent as much PG-NH2 substitution as possible I 
because attempts to block free amino groups by acetylation re sulted 
in immune recognition of the control albumin as well as the conjugate. 
After dialysis (PBS, 6X II, 48 hours) to remove excess PG, protein 
determinations and radioassays as described above I were used to 
calculate the number of moles of PG bound per mole of albumin. The 
average was 4.3 moles PG/mole albumin. Because the PG substitution 
of this conjugate was lower than for the PG- NH2 conjugate (see above), 
twice the quantity of PG-SH vs. PG-NH2 was used for sensitization 
(1 mg vs. 0.5 mg) and in vitro assays (100 mcg/ml vs. 50 mcg/ml) 
to keep the doses of bound penicillin similar for the two groups. 
Samples were diluted and frozen for later use. 
Sensitization of Animals. Male Hartley guinea pigs (300-
500 gms) were sensitized with various doses of the conjugated 
fractions in Complete Freunds Adjuvant (CPA)" 1.0 ml of the emulsion 
(1:1, vol./vol.) being distributed among the foot pads I nuchal and 
flank areas of each animal under ether anesthesia. Control animals 
received PBS with CFA. 
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Skin Tests. Intradermal skin tests were performed on the 
shaved abdomen of animals with 0.1 ml volumes of PG conjugates, 
control albumins, PG and penicilloyl poly lysine (generously provided 
by Kremers- Urban Co.) , twelve to fifteen days after sensitization. 
The test sites were read at 3-4 hours for erythema (immediate skin 
test) and at 24 hours for induration (delayed skin test). 
Harvesting of Cells for In Vitro Assays. To induce a peritoneal 
exudate cell (PEC) population, animals were given 20 ml of 1.0% 
casein (Eastman Kodak) in PBS intraperitoneally, 22-26 days after 
sensitization. Four days later, animals were sacrificed by 
exsanguination (cardiac puncture) under ether anesthe sia and PEC IS 
collected by washing the abdominal cavity with Hank ' s Balanced Salt 
Solution (HBSS). Red blood cells were lysed with 0.3 % saline and 
the PEC' swashed 3X with HBSS and suspended in RPMI - 1640 media 
with 50 J.I. g / ml Gentamycin (RPMI - G). A cell count and viability 
(trypan blue exclusion) was determined; usually 90-120x 106cells, 
always > 90% viable. Autologous lymph node cells (20-30 x 106 cells) 
were added to the PEC population for the Macrophage Migration Inhibition 
assays. 
Lymph node cells were obtained aseptically by teasing the 
cells out of the inguinal, popliteal and axillary lymph nodes into HBSS. 
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After aspirating the cells through sterile gauze to remove large pieces 
of tissue I they were washed 3X in HBSS and suspended in RPMI - G. 
Cell harvests ranged from 250 - 600 x 106/ animal and viability was 
generally? 70 % • 
Macrophage Migration Inhibition Assay. Peritoneal exudate 
cells (4 x 106/m l) were pre-incubated (60 - 90 min) with antigens 
and controls before being resuspended in 0.45 m 1 of RPMI- G , 5% 
Normal guinea pig serum (GIBCO or from our own normal animals) 
containing antigens and controls. After another 30 - 60 min incuba-
tion on ice I six capillary tubes were filled with the cell suspension 
for each antigen and control I and plugged with Crito- Seal (Sherwood 
Medical Industries). Cells were packed into buttons (250 x g I 
5 min) I and the capillaries scored and broken at or slightly below I 
the cell-liquid interface.. The four best capillaries (square I accurate 
breaks) were placed in (Lab-Tek) Tissue Culture Chamber Slides 
(8 chambers / slide) prepared with a spot of high vacuum grease in 
one corner of each chamber to hold the capillary in place I and filled 
(0.4 m 1 ) with the same antigen-containing media used to prepare 
the capillary tube s . After 24 hours in 5 % CO2 I 37
0 C I humidified 
atmosphere I the areas of migration were determined by projecting 
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the fans (see fig. 1) onto a wall with an overhead projector. The fans 
were traced on paper I and a polar compensating planimeter used to 
quantitate the area of migration using the following equation: % migra-
t
' mean area of 4 replicates of antigen (PG-NH2,PG-SH)or(PG,PPL) 
10n=--------------------------------------~----____________ _ 
mean area of 4 replicates of control (corresponding albumin)or(PBS) 
x 100%. 
Transformation-Incorporation of 3H -Thymidine. Triplicate 
cultures (2 ml/culture) of lymph node cells (1 x 106 cells/ml) were 
prepared for each antigen, controls and phytohemagglutinin (PHA- M I 
GIBCO) in plastic culture tubes (Falcon, 12 x 75 mm). The cultures 
were incubated for 96 hours in a 370 C, 5 % CO2 humidified atmosphere, 
3H -Thymidine (sp. ac. = 6.7 Ci / mM ) was added to each culture 
(0.5 mcCi in 0.05 ml of RPM!) for the last 24 hours of incubation. 
The cells were collected (1,000 x g I 15 min) and dissolved in 1.0 
ml of 0.1 N NaOH. The precipitate formed by addition of trichloro-
acetic acid (TCA, 1.0 ml, 12 %) was solubilized with NaOH and 
reprecipitated with TCA and washed. The final precipitate was 
solubilized with NaOH I and both the solubilized precipitate (1.0 ml) 
and the fluid from a rinse of the tube (0. 5 ml) placed in a scintillation 
vial with liquid scintillation cocktail (Aquasol, New England Nuclear) 
and counted at 40 C in a Nuclear Chicago Isocap 300 counter. 
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Results are expressed as stimulation index (S.1.) where: Stimulation 
RESULTS 
Sensitization of Animals to PG-GPA Conjugates - Effect of 
Hapten Density. Groups of 3 guinea pigs each were sensitized to 
three conjugates (PG1S-GPA, PG40-GPA, PG100-GPA) and skin 
tested to evaluate the ability of each conjugate to induce an 
immune response. The results of immediate and delayed skin tests 
are shown in Table 1. All sensitized animals were skin test positive 
to all 3 conjugates and negative to the 3 control albumins. CFA-
(control) animals were skin test negative to both the conjugates and 
the controls; although minimal "erythema ll was seen in two control 
animals, no induration developed. Overall, the least substituted 
conjugate (PG1S-GPA) appeared to induce a more positive response as 
judged by the size of the skin test, but the difficulty in quantitating 
skin tests and individual animal variability does not allow firm 
conclusions. 
Sensitization - Effect of Varying Dose of Conjugate. The 
results of skin tests for animals sensitized with 100 mcg I 500 mcg I 
1 mg and 2 mg of albumin containing IS PG per molecule are seen in 
Table 2. There were no significant differences, as judged by skin 
tests, between the different doses given; however I the highest dose 
(2 mg) appears to be somewhat less capable of inducing sensitivity. 
11 
In Vivo Specificity of Immune Recognition: PG-NH2 vs. 
PG-SH Sensitized Animals. Groups of nine animals each were 
sensitized to the PG4-SH (1 mg each) or PG1S-NH 2 (500 mcg each) 
albumin conjugates. So as not to expose all 18 animals to all 
antigens I 5 from each group were skin tested with the sensitizing 
antigen, its control, the other conjugate and its control, PG and 
penicilloyl-polylysine (PPL). The remaining animals in each group 
(4 ) were skin tested only with the sensitizing antigen and control 
albumin to confirm sensitization. As a group the PG-SH animals 
gave smaller skin tests (3-7 mm induration) than the ~G-NH2 
(6-9mm) group. In all cases I however I the animals did respond to 
the sensitizing conjugate but did not respond to the other conjugate. 
All animals failed to re spond to PG or PPL by skin test. 
Macrophage Migration Inhibition (MIF) Assay - In Vitro 
Specificity. The results of the MIF assay for the antigens PG-NH2 I 
PG-SH I PG and PPL in animals sensitized to PG-NH2 I PG-SH or 
CFA are given in Table 3. The means for the two sensitized groups 
were compared to the mean for C FA (control) group by one-tail 
Student's t-test for independent samples. The migration of peritoneal 
exudate cells (PEC) from PG-NH2 sensitized animals was significantly 
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inhibited by PG- NH2 in vitro when compared to control (p < .005 ) 
animals I but was not inhibited by PG-SH in vitro. The migration of 
cells from PG-SH sensitized animals was significantly inhibited by 
PG-SH in vitro (p < .05 ) when compared with controls I but not by 
the PG-NH2 conjugate. The results from the MIF assays agree with 
the skin test data and demonstrate the specific recognition of each 
conjugate by animals sensitized to that conjugate and failure to 
recognize the other conjugate. The less dramatic migration inhibi-
tion seen for PG-SH sensitized animals compared to PG-NH2 
sensitized animals in response to the sensitizing antigen ( also 
less significant statistically) correlates with the smaller skin tests 
seen in the PG-SH group. Neither the PG-NH2 or PG-SH group of 
animals showed significant MIF activity when PG or PPL were used as 
the in vitro antigens. 
Specificity of 3H-Thymidine (3H- TdR ) Uptake In Vitro by Cells 
3 from PG-NH2 and PG-SH Sensitized Animals. The uptake of H-TdR 
by lymph node cells from animals sensitized to PG-NH2 I PG-SH and 
CFA to PG-NH2 I PG-SH I PG and PPL in vitro are given in Table 4. 
Animal to animal variability is quite large I so while the triplicate 
cultures used to obtain the mean values given for each antigen and 
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control generally give relatively low standard errors of ± 3-15 % 
of the mean I the group means have large standard errors (± 8 - 38 %). 
The results of 3H- TdR incorporation are not as clear as those 
for the MIF assay. Some of the PG-NH2 sensitized animals did 
appear to respond to PG-NH2 and PG in vitro, but the stimulation 
observed is quite low (1. a - 1.9 x control). The CFA (control) 
animals also give variable responses; the mean stimulation index 
is less than 1. 0, which suggests possible toxic effects or non-
specific suppression by the PG-NH2 conjugate. The variability of 
responses in both sensitized and control groups make definitive 
conclusions unwarranted (although statistically interesting). The 
PG-SH sensitized animals also respond irregularly and weakly to 
the conjugates in vitro, and again the responses are not as pronounced 
as are generally seen in lymphocyte transformation studies. 
In Vitro Dose Response Effects - Migration Inhibition Assay 
and Lymphocyte Transformation. The variability in the in vitro 
responses between animals, especially for the 3H-Thymidine uptake 
studies, led to a brief investigation of the in vitro dose-response to 
PG-NH2 in four PG-NH2 , three CPA and two PG-SH sensitized animals. 
The results of the MIF assays for these animals for in vitro doses of 
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10,50, 100 and 500 ug/ml are given in Figure 2. No change in 
the % migration was observed for cells from the sensitized animals 
over the concentration range used I implying that at least over this 
50 fold range, the MIF as say is an all or none phenomenon. The 
PG-SH pig (only 1 of 2 had sufficient PEC's for the assay) also 
appears to respond somewhat to the 100 and 500 ug / ml doses of 
3 PG-NH2 , but H-TdR uptake results (see below) do not support 
this observation. 
The dose response for the incorporation of 3H-Thymidine by 
lymph node cells from control and sensitized animals for in vitro 
doses of PG-NH2 from 10-500 ug / ml are shown in figure 3. The 
trend seen for each individual animal is also seen for the group, i. e. , 
increased incorporation of 3H-Thymidine as the in vitro dose of 
antigen is increased. Results obtained for these animals indicate 
a higher dose (500 mcg / ml or perhaps more) of conjugate is more 
effective in stimulating the incorporation of 3H -TdR by sensitive 
cells, than was seen in the specificity experiments (see above) 
where an!!!. vitro dose of SO mcg / ml was employed. The incorpora-
tion of 3H- TdR by cells from sensitized animals when challenged with 
the sensitizing antigen increased 2-4 fold over media or control 
albumin levels I and even more when compared to CFA (control) 
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animals where the stimulation indices again were less than the 
expected ratio of 1.0. Animals sensitized to PG-SH had low stimu-
lation indexes similar to those for control animals I indicating 
failure to recognize the PG-NHZ conjugate at the doses used. 
DISCUSSION 
Macrophage Migration Inhibition (MIF) and Lymphocyte 
Transformation are thought to be in vitro correlates of cell-mediated 
immune reactions (7 , 11 ). In vivo and in vitro studie s de signed to 
investigate the specificity of immune recognition for these cell-
mediated phenomena have demonstrated a rather high degree of 
specificity for both hapten(12 , 13,14) and carrier (15,7, 16). The 
specificity of recognition is particularly important for drug hyper-
sensitivities because a minor metabolite or breakdown product may 
induce the allergy. This investigation was designed to determine 
if the same drug conjugated to the same carrier, but through different 
chemical linkage s, would be recognized as different antigens by 
in vivo and in vitro technique s, The variety of reactions which 
occur between penicillin and proteins seemed to provide the oppor-
tunity to investigate this possibility. Guinea pigs were used as 
experimental model, and guinea pig albumin as the carrier protein. 
To simulate as nearly as possible what may occur in vivo, the 
conjugation reactions were performed at pH = 7.4 and 370 C where 
possible. 
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The results of delayed skin tests for animals sensitized to 
penicillin-albumin conjugates bound through amino (PG-NH2) or 
sulfhydryl (SH) moietie s of albumin support the evidence sugge sting 
highly specific immune recognition for cell-mediated reactions. Even 
though the hapten and carrier were the same I the difference in linkage 
resulted in two different antigens I which were not cross reactive. 
The Macrophage Migration Inhibition (MIF) assays also 
confirm this high degree of specificity for elicitation of the immune 
response. Cells from animals sensitized to the PG-NH2 conjugate 
responded to PG-NH2 in vitro but did not respond to the PG-SH 
conjugate. The cells from the PG-SH sensitized animals were inhi-
bited by PG-SH, but not by PG-NH2 • Herman and Sams (20) showed 
that hapten alone VJOuld not inhibit the migration of peritoneal exudate 
cells (PEC) from guinea pigs photosensitized to tetrachlorosalicylanilide 
(TCSA), but that the hapten conjugated to autologous protein would 
inhibit the migration of sensitized cells. Our experiments also indicate 
a high degree of specificity for the conjugate, since PG alone did not 
significantly inhibit the migration of ce lIs from either sensitized group. 
Using 5 mg / ml of PG and 10% normal guinea pig serum, Girard and 
Cuevas (22) obtained positive MIF results and 3H- TdR incorporation 
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in vitro with PG alone for animals sensitized to PG-guinea pig gamma-
globulin I PG-guinea pig albumin or PG alone" The se concentrations 
may have resulted in sufficient conjugation of PG to the proteins of 
serum to form the conjugates necessary to obtain positive in vitro 
results. They also noted that the PG-protein conjugates inhibited the 
migration of macrophages better than PG alone. Our data supports this 
idea because although MIF assays were negative for PG I the sensitized 
lymphocytes appear to respond (weakly) to PG alone with an increase in 
3 the uptake of H-TdR. 
The possibility that immune recognition was directed against the 
albumin, through some alteration in tertiary structure induced by the 
conjugation procedures was also considered I but the control albumins 
used throughout the experiments were kept as similar to the conjugate s 
as possible Ii. e" I denatured and renatured or conjugated with DTNB 
to control for this possibility. In addition I the cross recognition of 
the three different conjugates in the experiments on epitome density 
strengthen the argument for hapten recognition since widely varying 
degrees of hapten substitution would not be expected to result in 
identical modification of the carrier protrin" 
The question of whether penicilloyl-polylysine (PPL) can act 
as a substitute for PG-NH2 -protein induced cell-mediated responses 
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for in vivo (21) or in vitro assays has not been resolved. Glauser, 
et al (21) did ob serve positive MIF te sts to PPL in 2 of 17 humans 
thought to have delayed hypersensitivity to penicillin. Our results 
suggest some inhibition of migration by cells from PG-NH2 sensitized 
animals, but the difference is not significant when compared to the 
C FA (control) group I when challenged with PPL. Even though the 
chemical linkage for PPL is the same as for the conjugate inducing the 
allergy I the carrier specificity requirements for cell mediated reactions 
may require an amino acid sequence more similar to the inducing carrier 
than polylysine, thus I further study of this antigen with other doses 
and with polylysine alone for control, appear nece s sary . 
Investigators have been both successful and unsuccessful in 
confirming drug allergies with the lymphocyte transformation assay 
in sensitive individuals (23, 24 I 25 , 26). The reasons for the se 
re sults probably include the nature of the drug, the time of incubation I 
the concentration of the drug and the presence of suitable carrier 
proteins in the culture media (27). Presumably the drug must be 
conjugated to the carrier ( s ) or a carrier similar to the one ( s) which 
induced the .!!l vivo response in order to obtain positive .!!l vitro 
results. Our data suggests that conjugates of PG-GPA used to induce 
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hypersensitivity will also stimulate the incorporation of 3H -TdR by 
lymph node cells in vitro. The specificity of this stimulation is 
not clear however, because the level of stimulation is not very high. 
The reason for the weak responses appears to be due, at least in 
part, to the use of in vitro doses of antigen which are below the 
optimum I since PHA responses indicated the cells were capable of 
20-50 fold increases in 3H- TdR uptake, over unstimulated controls. 
The apparent depression in the stimulation indexes of control 
animals makes toxic or suppressive effects of the PG-GPA conjugates 
and PG a possibility (see table 4). Possible toxic effects are promi-
nent in the cultures with PG (2 mg/ml). The mean stimulation index 
( s. I. ) for C FA (control) animals is O. 32 I while for the PG- NH2 
sensitized animals the mean is 0.89 I which implies stimulation, how-
ever, the variability and low values for both groups make conclusions 
difficult . 
The in vitro dose effects for MIF and transformation assays 
were briefly examined for the PG-NH2 antigen to resolve some of the 
animal to animal variability. The MIF assay ,over the limited dose 
range used (50 fold) I yielded results which were consistent with 
those from the specificity experiments I and gave no indication of a 
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better in vitro response with increased dose. The transformation 
assay results resemble those of other investigators (28, 29, 30), 
i. e. I more stimulation of 3H -TdR uptake as the in vitro dose of 
antigen was increased. This phenomenon would seem to provide an 
opportunity to quantitate cell-mediated immunity. Levis et ale (31) 
did observe more 3H -TdR uptake by cells from individuals with larger 
skin tests, while Schlossman et al.( 6 ) were unable to show a signi-
ficant difference in the in vitro response between sensitized animals 
which were skin test positive and others which were skin test negative 
for a given skin test dose. The increasing incorporation of 3H -TdR 
as the in vitro dose of antigen increased has been attributed to 
differences in clone responsiveness, i.e. several clones of cells 
with different sensitivity to the antigen being stimulated to respond 
at different in vitro doses (28), or to a soluble mediator which is 
released by sensitized cells which induces nonsensitized cells to 
incorporate 3H -TdR (29). The linear re sponse of 3H -TdR incorporation 
by cells from sensitized individuals in response to increasing doses 
of antigen in vitro vs. little or no change in 3H- TdR uptake for controls 
or weakly sensitized individuals may provide a more accurate quantita-
tive measure of sensitivity than the usual criteria of a 2-3 fold increase 
in 3H- TdR uptake with one given dose of antigen. 
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Penicillin is one of the few drugs which has the ability to 
react with proteins to form covalent conjugates in itl s native form 
or with spontaneous breakdown products (9). Penicillin can react 
with free amino (NH2) groups of proteins to form a penicilloyl 
group, which appears to be the antigenic determinant responsible 
for a major portion of penicillin allergy(9). The discovery of the 
penicilloyl conjugate led to the synthesis of penicilloyl polylysine 
(PPL) for use in skin testing individuals with suspected PG allergy. 
This artificial antigen is thought to be small enough to not stimulate 
immune recognition and induce sensitivity but will, in some cases 
detect allergy (esp. anaphylactic) to PG. Penicillin will also react 
with sulfhydryl (SH) groups of proteins to form a disulfide bound 
conjugate which also occurs in vivo (Price and Lawrence, manuscript 
in preparation). Since both of these conjugates (PG-NH2 and PG-SH) 
are formed in vivo, the immune response could be directed against 
one or both of them, and the ability to detect the allergy might depend 
on having the same type of conjugate in vitro. 
When high concentrations of PG were reacted with guinea pig 
albumin, conjugates ranging from 4 to 100 moles PG / mole albumin 
were formed. One hundred PG / albumin would seem to exceed the 
number of available reactive groups on one albumin molecule f 
suggesting that dimers or polymers of PG (9 ) may also react with 
proteins to form covalent conjugates. 
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The influence of epitome density (number of haptens per 
carrier protein) has been studied by several authors( 14 I 17, 18) and 
some differences between lowly and highly substituted conjugates 
to induce immune responses have been observed. Highly substituted 
carriers tend to be less immunogenic and more capable of inducing 
tolerance. Penicillin-G was conjugated to guinea pig albumin to 
obtain several different epitome densities (15, 40, and 100 moles 
PG / mole albumin) to see if any major differences in cell-mediated 
immunity would result, as judged by delayed skin test. The data 
indicates none of the conjugates was obviously superior to the others, 
however, our data does suggest that decreased sensitivity may be 
induced by the highly substituted (PG1 00 -GPA) conjugate. 
When extremely high or low doses of antigen are used for 
immunization, tolerance instead of immunity to the antigen has been 
reported to occur ( 19). We were unable to demonstrate any outstanding 
differences in sensitivity over a 20 fold range of the immunizing dose 
with the PG-GPA conjugate, but the highest dose (2 mg) may be 
slightly less capable of inducing sensitivity. 
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TABLE 1 
Intradermal skin test results after sensitization with different epitome densities of 
Penicillin per albumin carrier. 
ANIMALS SENSITIZED WITH ANIMAL PG100-GPA GPA 
100 Meg EACH OF: # I D I D I D I D 
PG1OO-GPA 1 + 4 + 4 + 7 0 
2 + 7 ++ 5 ++ 6 0 
3 + 6 + 4 + 6 0 
PG40-GPA 1 ++ 7 ++ 4 ++ 8 0 2 + 7 + 3 + 6 0 
3 + 6 ++ 3 ++ 9 0 
PG15 -GPA 1 ++ 4 
++ 8 ++ 9 0 
2 ++ 6 + 4 ++ 8 0 
3 ++ 5 + 5 + 9 0 
Control-CFA 1 0 0 0 0 
2 + 0 0 0 0 
3 0 0 + 0 0 
I = Immediate skin test I - = negative I + = minimal erythema I ++ = brisk erythema I 4 hours N (X) 
after challenge with 50 mcg GPA-PG conjugate. 
D = Delayed skin test I diameter of induration in mm 24 hours after challenge. 
TABLE 2 



































Immediate = erythema, + = minimal, ++ = brisk, 3 hours after challenge. 
Delayed = mm induration 24 hours after challenge. 
TABLE 3 
Results of Macrophage Migration Inhibition Assays for Guinea pigs sensitized to PG-NHZ I 
PG-SH and CFA cultured with PG-NH2 I PG-SH I PG and PPL in vitro. Values given are 
migrations (mean of quadruplicate s) expre s sed as % of control. 
ANIMALS SENSITIZED WITH: 
In Vitro Antigen: 
(cone. ) 
PG-NH2 (50 meg/mO 
PG-SH (100 meg/ml) 
PG (2 mg/ml) 
PG-NH PG-SH 
500 mcg2 1 • 0 mg 
72 ± 7 (29-90) [8] * 93 ± 5 (72-110) [8] 
p < .005** 
104± 3 (89-111) [8] 87± 4 (73-106) [6] 
p <.05 
86 ± 5 (73-95) [7] 83 ± 6 (61-108) [7] 
79 ± 4 (68-87) [5] 84 ± 3 (72-92) [7] 
* mean ± S. E. (range) [number of animal s] 
** p value compared to CFA-Control by one-tail Student's t-test. 
CFA (Control) 
98 ± 2 (92-108) [6] 
102 ± 4 (95-108) [3] 
92 ± 7 (76-112) [4] 




Results of 3H-Thymidine uptake in vitro for lymph node cells from guinea pigs sensitized to PG-NH2 , 
PG-SH and CFA when cultured with PG-NH2 , PG-SH I PG and PPL. Values are expressed as Stimulation 
Index (ratio of mean of triplicate cultures of antigen stimulated over mean of triplicate control 
stimulated cultures.) 
IN VITRO 
ANTIG EN ( cone. ) 
PG-NH2 (50 mcg/ml) 
PG-SH 





1 .39 ± . 15 (.91-1.85) [7] * 
1 • 2 3 ± . 13 (. 7 2 -1 • 83) [7] 
.89± .11 (.60-1.27) [5] 
1.90 ± .64 (.84-4.9) [6] 
* Mean ± S. E. (range) [Number of animals] 
ANIMALS SENSITIZED WITH: 
PG-SH 
1.0 mg 
1 .57 ± . 34 (. 70- 2 . 66) [6] 
1.50± .29 (.82-2.50) [6] 
.79± .13 (.44-1.26) [6] 
1.27± .. 18 (.72-1.7) [5] 
CPA (Control) 
.73 ± . 14 (. 18-1. 22) [8] 
. 98 ± . 08 (. 61-1 . 18) [7] 
.32± .12 (.11-.68) [5] 




Figure 1: Photograph of chamber slide showing placement of grease 
and capillary tube s containing peritoneal exudate celIs. Fans of 
cells from PG-NH2 sensitized animal after 24 hour incubation--




Figure 2: Results of macrophage migration inhibition assay with 
in vitro doses of PG-NH2 from 10-500 mcg/ml for cells from 
CFA (control) I PG-NH2 I and PG-SH sensitized animals. Each 
point is the mean area of migration ( as % of control ) of 
quadruplicate assays for number of animals shown in brackets I 
bars show S. E. 
MACROPHAGE MIGRATION INHIBITION ASSAY 
110 
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Figure 3: Uptake of 3H-Thymidine by cells from animals sensitized 
to CPA (control), PG-NH2 and PG-Sh incubated with PG-NH2 
(10-500 mcg/ml). Results are expressed as mean of Stimulation 
Index (ratio of triplicate PG- NH2 conjugate stimulated vs control 
albumin stimulated cultures) for number of animals shown in 
brackets ± S. E. (bars). 
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